Author

Robert Lum

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Dawiyat MassoudiiD· 1 shared Mei‐Sze ChuaiD· 1 shared Mingdian TaniD· 1 shared Renumathy DhanasekaraniD· 1 shared Samuel K. SoiD· 1 shared Steve Schow· 1 shared Yi LiuiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Dawiyat MassoudiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A Novel Niclosamide Sulfate Prodrug with Enhanced Bioavailability Suppresses Hepatocellular Carcinoma via Inhibition of Multiple Signaling Pathways

Mingdian Tan, Steve Schow, Yi Liu, Robert Lum, Dawiyat Massoudi, Renumathy Dhanasekaran, Samuel K. So, Mei‐Sze Chua

This paper develops a niclosamide sulfate prodrug, SSL-0024, which improves solubility and bioavailability, showing strong anti-tumor effects against hepatocellular carcinoma through multiple pathway inhibition.

bioRxiv · Apr 15, 2026 · PreprintCancer Biology